Three-dimensional (3D) bioprinting is an additive manufacturing process resulting in constructs containing living cells. Key components of this process include bioprinters—devices that work like 3D ...

Engineers from UNSW Sydney have developed a miniature and flexible soft robotic arm that could be used to 3D-print biomaterial directly onto organs inside a person's body. 3D-bioprinting is a process ...

A team of researchers from the National University of Singapore (NUS) has developed a method to fabricate personalised gingival (gum) tissue grafts using an innovative combination of 3D bioprinting ...

Advances in regenerative medicine are transforming how we approach tissue and organ repair, offering patient-specific and functional alternatives to ...

Researchers at Pennsylvania State University have developed a method to patch up injuries by 3D printing both hard and soft tissues at the same time, using two different “bioinks.” In tests on rats, ...

What just happened? Another technology that's long been the thing of sci-fi has taken its first steps to becoming a reality: 3D bioprinting complex human organs. The concept of being able to 3D-print ...

The global 3D bioprinting market size was US$ 1.78 billion in 2021. The global 3D bioprinting market size is forecast to reach US$ 10.3 billion by 2032, growing at a ...

In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (NYSE: DDD) and Desktop Metal (NYSE: DM) entering the commercial bioprinting market this year.

In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (DDD-1.62%) and Desktop Metal (DM) entering the commercial bioprinting market this year. Bioprinting ...

Investing in 3D bioprinting stocks is a highly speculative and specialized approach to the biotech industry in general. That’s because it blends two relatively niche technologies to create a broader ...